Malin Corporation reported EUR15.4M in Cost of Sales for its fiscal semester ending in December of 2020.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
ALKERMES USD 49.46M 263K Jun/2025
Avita Medical AUD 2.28M 170K Dec/2024
Eurofins Scientific SE EUR 2.83B 93.8M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Lonza CHF 2.47B 532M Dec/2024
Malin Corporation EUR 15.4M 0 Dec/2020
Moderna USD 119M 29M Jun/2025
Organon & Co USD 720M 48M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025